Aberrant White Matter Microstructure as a Potential Diagnostic Marker in Alzheimer’s Disease by Automated Fiber Quantification

doi:10.21203/rs.3.rs-31270/v1

Download PDF

Research

Aberrant White Matter Microstructure as a Potential Diagnostic Marker in Alzheimer’s Disease by Automated Fiber Quantification

https://doi.org/10.21203/rs.3.rs-31270/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

Background: Alzheimer’s disease (AD) has been primarily considered a progressive neurodegenerative disorder of gray matter. Neuroimaging evidence has suggested white matter microstructure are also heavily affected in AD. However, whether white matter dysfunction are localized at the specific regions of fiber tracts and whether they would be a potential biomarker for AD remain unclear.

Methods：By automated fiber quantification (AFQ), we applied diffusion tensor images from 25 healthy controls (HC), 24 amnestic mild cognitive impairment (aMCI) patients and 18 AD patients to create tract profiles along 16 major white matter fibers. We compared diffusion metrics [Fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (DA) and radial diffusivity (DR)] at the global and local level of fiber tracts between groups. Partial correlation analyses were used to explore the associations between white matter changes and cognitive performance. To assess the diagnostic value, we enrolled the significantly altered diffusion metrics into a random forest (RF) classifier, a type of machine learning method.

Results: In the global tract level, we found that aMCI and AD patients showed higher MD, DA and DR values in some fiber tracts mostly in the left hemisphere compared to HC. In the point-wise level, widespread disruption were distributed on specific locations of different tracts. The point-wise MD measurements presented the best classification performance with respect to differentiating AD from HC. The two most important variables were localized in the prefrontal potion of left uncinate fasciculus and anterior thalamic radiation. In addition, the point-wise DA in the posterior component of the left cingulum cingulate displayed the most robust discriminative ability to identify AD from aMCI.

Conclusion：Our findings provide evidence that the left-sided microstructural integrity was vulnerable in white matter fiber tracts in AD. Furthermore, the frontal lobe portion of left uncinate fasciculus and anterior thalamic radiation and the posterior component of the left cingulum cingulate played the important role in the diagnosis and surveillance of AD. These results demonstrated the potential of white matter abnormalities as a diagnostic biomarker in AD.

Neurology

Alzheimer’s disease

automated fiber quantification

white matter microstructure

uncinate fasciculus

anterior thalamic radiation

cingulum cingulate

Alzheimer’s disease (AD), the most common type of dementia in the elderly, is a growing global public health concern with enormous implications for individuals, families and society [1]. Due to the distribution of its hallmark pathological changes [amyloid plaques (Aβ) and neurofibrillary tangles (NFT)], AD has traditionally been regarded as a disease of the brain’s gray matter [2]. In recent years, neuroimaging studies have implicated white matter microstructural abnormalities in AD, suggesting that in addition to the features of neuronal loss, white matter alterations may be the important pathophysiological characteristics of AD [3]. However, our knowledge about white matter degeneration in AD is still limited compared to what we know about gray matter atrophy [3]. In particular, whether the patterns of white matter changes are different across fiber tracts and whether they would be a promising biomarker for AD remain largely unknown.

From two perspectives, previous neuroimaging and neuropathological studies explained white matter damage in the progression of AD. First, white matter deficits have been considered a secondary result of gray matter pathology through Wallerian-like degeneration, which is the process of antegrade degeneration of the axons following neuronal cell body lesions [4]. The postmortem evidence has suggested that white matter abnormalities (especially in parietal lobe) may be related to Wallerian-like degeneration triggered by the deposition of cortical pathology (Aβ and NFT) in AD, whereas white matter damages in the normal elderly are due to ischaemia [5]. Alternatively, it is possible that white matter degradation could be directly caused by AD pathology, independently of gray matter changes. Using a quantitative neuroimaging method, Douglas C et al found that myelin water fraction was negatively related to levels of cerebrospinal fluid (CSF) biomarkers across brain white matter in preclinical AD [6]. Additionally, Sara E. Nasrabady et al reviewed different mechanisms such as oxidative stress, ischemia, iron overload, excitotoxicity, Aβ toxicity and tau pathology, which could affect myelin and oligodendrocytes in AD [3]. Given the above, the precise pathogenetic mechanisms of AD-related white matter degeneration are likely complex and synergistic.

Diffusion tensor imaging (DTI) has been a widely-used tool to detect microstructural integrity of white matter. Fractional anisotropy (FA) and mean diffusivity (MD) are two common quantitative metrics of DTI that detect the directionality and displacement of water diffusion. Several DTI-analytic approaches, including regions of interest (ROI)-based analysis, voxel-based morphometry (VBM) and tract-based spatial statistics (TBSS) have been used in AD-related studies. A cross-sectional study have reported that AD patients experienced significantly lower FA and higher MD in the regions of splenium and fornix compared with either normal elderly or mild cognitive impairment (MCI, the early stage of dementia) by the ROI-based method [7]. However, this method is subject to theoretical hypotheses of regions of pathologic damage, making localization difficult. Results from VBM analysis, which is hypothesis-independent, have shown that AD patients with a high Braak NFT stage had significantly elevated MD values in the crus of fornix, precuneus, cingulum and temporal white matter [8]. Note that the VBM method does not have sufficient precision, particularly for patient populations at the individual level due to varied shapes of long-range fiber bundles among subjects [9]. By contrast, TBSS, a skeleton-based approach, was proposed to reduce effects of local misregistration. Weiler M et al demonstrated that AD patients exhibited a progression of white matter degeneration over time involving the widespread white matter regions by applying TBSS [10]. Nevertheless, this method couldn’t completely overcome the cross-subject co-registration problem [11]. Furthermore, tissue diffusion properties may change along each tract because diseases can strike at different local positions within the bundle [12]. Thus, an ideal method of the localization-specific properties along each fiber tract at the individual level may provide more detailed information about white matter abnormalities in AD.

Automated fiber quantification (AFQ) is a new analyzing method that applies a deterministic tractography approach to recreate whole-brain white matter tracts and estimate point-wise diffusion parameters aimed at the specific tract [12]. Recently, AFQ has been successfully applied to psychiatric disorders and development studies.

Deng F and colleagues suggested that the bipolar disorder and the major depressive disorder may be characterized by distinct alterations in the specific location of brain fiber tracts, particularly in the prefrontal portion of the right uncinate fasciculus (UF) and left anterior thalamic radiation (ATR) [13]. Using AFQ, two different patterns of white matter changes have been found in the early stage of schizophrenia, representing a potential approach to resolve the neurobiological heterogeneity of the schizophrenia syndrome [14]. Huber E et al proposed that an intensive learning training could cause the rapid alterations in tissue diffusion properties within the left arcuate fasciculus and inferior longitudinal fasciculus (ILF) [15]. Consequently, AFQ may provide a promising strategy to investigate whether white matter microstructural integrity is abnormal along the entire tract or at the specific location on a tract in the progression of AD.

In this study, we aimed to utilize AFQ tractography method to explore the altered pattern of white matter fiber tracts across AD and amnestic MCI (aMCI, the prodromal stage of AD) compared with healthy controls (HC). Furthermore, we combined white matter diffusion metrics with a machine learning algorithm, random forest (RF), to make predictions for HC, aMCI and AD at the individual level. We hypothesize that white matter disruption may vary along fiber tracts in different patterns, which is associated with AD-related cognitive impairment, and may provide potential candidate hallmarks for its early diagnosis.

Participants

Eighty-one elderly subjects participated in this retrospective study, including 26 aMCI patients, 30 AD patients and 25 HC. The aMCI and AD patients were recruited from the Memory Clinic of the Neurology Department, Nanjing Drum Tower Hospital and the demographically matched HC were recruited from the local community. This research was approved by the Ethics Committee of Nanjing Drum Tower Hospital, and informed consents were obtained from all participants.

All participants underwent a complete neurological evaluation, standard laboratory tests, neuroimaging examination and an extensive battery of neuropsychological assessments. The possible or probable AD was diagnosed based on the National Institute of Neurological and Communicative Disorders and Stroke and the AD and Related Disorders Association (NINCDS-ADRDA) and the Diagnostic and Statistical Manual of Mental Disorders IV criteria (DSM-IV) guidelines [16–17]. The aMCI patients included in this study were diagnosed according to the recommendations of Petersen and described as follows [18]: (1) memory complaint confirmed by the subject and/or an informant; (2) objective cognitive performance documented by an auditory verbal learning test-delayed recall (AVLT-DR) scores below or equal to 1.5 SD of education- and age-adjusted norms; (3) clinical dementia rating (CDR) score = 0.5; (4) the scores for the Mini-Mental State Examination (MMSE) ≥ 24; and (5) not sufficient to dementia according to NINCDS-ADRDA and DSM-IV. More detailed information about the criteria of aMCI has been described in our previous study [19]. The HC subjects were required to have MMSE scores ≥ 26 and CDR score of 0. In addition, participants with a history of other psychiatric or neurological disease (e.g., stroke, depression, traumatic brain injury and others) were excluded in the current study.

MRI scanning

All of the subjects were examined on a 3.0T MRI scanner (Philips Medical Systems). The protocol included the diffusion-weighted imaging (DWI) sequence [echo time (TE) = 55 ms, repetition time (TR) = 9154 ms, FOV = 224 × 224 mm², acquisition matrix = 112 × 112, voxel size = 2 × 2 × 2.5 mm³, thickness = 2.5 mm, 32 gradient directions (b = 1000s/mm²) and 1 b0 image], the high-resolution T1-weighted imaging [TE = 4.6 ms, TR = 9.8 ms, flip angle (FA) = 8°, FOV = 250 × 250 mm², acquisition matrix = 256 × 256, number of slices = 192, thickness = 1.0 mm] and the FLAIR sequence [TE = 333 ms, TR = 4500 ms, time interval (TI) = 1600 ms, voxel size = 0.95 × 0.95 × 0.95 mm³, number of slices = 200, acquisition matrix = 270 × 260].

Neuropsychological mesurement

All participants underwent the standardized neuropsychological assessments performed by an experienced neuropsychologist [20]. General cognitive functioning was evaluated by MMSE. The multiple cognition domains including episodic memory, executive function, language, information processing speed and visuospatial function were also evaluated. The detailed neuropsychological battery consisted of AVLT-DR, Wechsler Memory Scale Visual Reproduction-delayed recall (WMS-VR-DR), Boston Naming Test (BNT), Category Verbal Fluency (CVF), Visual Reproduction-copy (VR-C), Clock Drawing Test (CDT), Stroop Color and Word Tests A, B and C (Stroop A, B and C) and Trail Making Test-A and -B (TMT-A and TMT-B). The raw scores were Z-transformed in order to calculate the composite score of each cognitive domain.

Magnetic resonance image pre-processing

For DWI images, the preprocessing included DICOM-to-NIfTI format, registering DWI images to the non-DWI image, eddy current correction and deleting the non-brain tissue using the FMRIB Software Library (FSL) version 5.0.9 (https://www.fmrib.ox.ac.uk/fsl). Finally, the whole-brain diffusion images [ FA, MD, axial diffusivity (DA) and radial diffusivity (DR)] were obtained by DTIFIT.

Automated fiber quantification procedure

We identified whole-brain white matter tracts (including 20 major fiber tracts), and further calculated the diffusion measurements along the tract fiber by utilizing the AFQ script (https://github.com/yeatmanlab/AFQ) [12]. A brief description of the processing steps is as follows: (1) the deterministic tractography with the thresholds of FA > 0.2 and turning angle < 30°; (2) the waypoint ROI-based tract identification as described in the previous research [21]; (3) the tract refinement based on the fiber probability maps [22]; (4) fiber tract cleaning applying the outlier rejection algorithm [12]; (5) quantification of the diffusion metrics along each fiber tract at 100 equidistant nodes. The identified 20 white matter tracts are listed in Table 1. Since AFQ uses the strict criterion for tract segmentation, it is possible not to identify all 20 fiber tracts in each subject [23]. We excluded 4 fiber tracts (the arcuate fasciculus and bilateral bilateral cingulum hippocampus) which were difficult to be identified than the others (Supplementary Table 1). Table 1 shows the detailed demographic and neuropsychological data of subjects in which AFQ identified all 16 tracts, and only these subjects (HC, n = 25; aMCI, n = 24; AD, n = 18) are into the further analyses.

Table 1

Demographic and neuropsychological data. There was no significant difference for age, gender distribution and years of education between three subgroups (p > 0.05). The AD patients showed poorer performances on MMSE (p < 0.001) than HC and aMCI. The aMCI group exhibited significantly lower scores in information processing speed (p < 0.011), episodic memory (p < 0.001), language (p < 0.013), visuospatial processing function(p < 0.002) and executive function (p < 0.002) than HC group. Abbreviation: HC, health control; aMCI, amnestic mild cognitive impairment; AD, Alzheimer’s Disease; MMSE, mini mental state examination; AVLT-DR, Auditory Verbal Learning Test-delayed recall; VR-DR, visual reproduction-delay recall; WMS, Wechsler Memory Scale; CVF, category verbal fluency; BNT, Boston Naming Test; CDT, Clock Drawing Test; VR-C, visual reproduction-copy; TMT-A and TMT-B, Trail Making Test-A and B; Stroop A, B and C, Stroop Color and Word Tests A, B, and C.

Statistical and machine learning analyses

Demographic characteristics (e.g., age, gender, and years of education) and cognitive performance were compared using the Chi-squared (χ2) test, two-sample t test or one-way analysis of variance (ANOVA) in SPSS software Version 22 (IBM Corp., Armonk, New York). The significant threshold was set at P < 0.05.

To examine between-group difference in the global tract level, we calculated DTI measurements of 16 fiber tracts and performed the ANOVA. Age, gender and years of education were controlled as confounding covariates.

Then, the point-wise analyses were conducted by “Randomize” command of FSL software. Age, gender and years of education were included as confounding covariates in the general linear model (GLM). The false discovery rate (FDR) correction was used to determine the significance for p values (p < 0.05) [14] and only greater than or equal to 3 adjacent nodes were reported [24]. To explore the relationship between white matter microstructural integrity and cognition, partial correlation analyses were performed by SPSS while controlling for age, gender and years of education.

Finally, we applied the random forest (RF) classifier to identify the white matter diffusion metrics that best predicted the disorder diagnosis. Only those features significantly different between groups were considered in this analysis. In our research, RF was constructed with 500 trees [25]. Every decision tree was built by a bootstrap sample from the training data. The out-of-bag (OOB) performance was predicted to obtain the unbiased estimation of the misclassification. The variable importance was ranked based on the OOB data. The diagnostic ability of the neuroimaging features was evaluated according to accuracy, sensitivity and specificity.

Demographic and clinical characteristics

Demographic and clinical information for the HC, aMCI and AD in which AFQ successfully identified all 16 fiber tracts were provided in Table 1. There was no significant difference for age, gender distribution and years of education between three subgroups (p > 0.05). The AD patients showed poorer performances on MMSE (p < 0.001) than HC and aMCI. Because the AD patients didn’t cooperate or understand the questions, a large number of cognitive domain assessment scores were missing. So, we mainly compared the multiple cognitive domain performance between HC and aMCI. The aMCI group exhibited significantly lower scores in information processing speed (p < 0.011), episodic memory (p < 0.001), language (p < 0.013), visuospatial processing function(p < 0.002) and executive function (p < 0.002) than HC group.

Between-group difference in diffusion metrics and its relationship with cognition

Between-group difference in the global fiber tracts and point-wise level was determined by diffusion metrics (FA, MD, DA and DR) with AFQ.

FA. No significant between-group difference was found in the fiber tract level (ANOVA, p > 0.05; Supplementary Table 2) and point-wise level (FDR correction, p > 0.05).

MD. In the fiber tract level, the left ATR, ILF, corticospinal tract (CST), cingulum cingulate (CC), inferior fronto-occipital fasciculus (IFOF), superior longitudinal fasciculus (SLF) and forceps minor exhibited the significant difference between HC, aMCI and AD (Table 2). The further analysis indicated that the AD patients showed significantly increased MD in these fiber tracts compared to HC and aMCI group. However, no significant alteration was observed between HC and aMCI.

In the point-wise comparison, significantly altered locations of fiber tracts (FDR correction, p < 0.05) were as follows: (1) the anterior component of the left ATR (nodes 1–13); (2) the anterior component of the right ATR (nodes 1–8); (3) the intermediate and posterior component of the left CC (nodes 1–6; nodes 28–36; nodes 64–69); (4) the widespread distribution of the forceps minor (nodes 1–8; nodes 43–50; nodes 95–100); (5) the anterior component of the left IFOF (nodes 66–69); (6) the posterior component of the right IFOF (nodes 1–7); (7) the frontal lobe portion of the left UF (nodes 75–100); (8) the frontal lobe portion of the right UF (nodes 74–91) (Fig. 1). The further post-hoc comparisons were showed in Table 3. In the point-wise level, the AD patients showed significantly increased MD in these locations of the fiber tracts compared to HC and aMCI group. It should be noted that aMCI obtained significantly higher mean MD values compared to HC in the frontal lobe portion of the left UF (nodes 75–100).

DA. Supplementary Table 3 showed DA values of each fiber tract. The left ATR, bilateral CST, forceps minor, left IFOF, left ILF, left SLF and left UF displayed significant differences between HC, aMCI and AD. The further post-hoc analyses were also listed in Supplementary Table 3.

Significant alterations in the point-wise comparison (FDR correction, p < 0.05) were mainly located in these tracts as follows: (1) the anterior component of the left ATR (nodes 1–27); (2) the anterior component of the right ATR (nodes 1–9); (3) the superior portion of the left CST (nodes 71–100); (4) the superior portion of the right CST (nodes 80–88; nodes 92–100); (5) the posterior component of the left CC (nodes 1–10); (6) the widespread distribution of the forceps minor (nodes 1–12; nodes 43–53; nodes 92–100); (7) the anterior and posterior component of the left IFOF (nodes 5–10; nodes 65–69; nodes 93–100); (8) the anterior component of the right IFOF (nodes 85–89); (9) the frontal lobe portion of the left UF (nodes 75–91) (Supplementary Fig. 1). The further post-hoc comparisons were listed in Table 3.

DR. Supplementary Table 4 showed that the three groups exhibited significant differences in the left CC and left ILF. The further multiple comparisons were showed in Supplementary Table 4.

In point-wise comparison, significantly altered locations of fiber tracts (FDR correction, p < 0.05) were as follows: (1) the anterior component of the left ATR (nodes 1–9); (2) the anterior component of the right ATR (nodes 1–3); (3) the anterior component of the left CC (nodes 77–81); (4) the posterior component of the right IFOF (nodes 1–6); (5) the frontal lobe portion of the left UF (nodes 91–100); (6) the frontal lobe portion of the right UF (nodes 78–91) (Supplementary Fig. 2). The further post-hoc analyses were showed in Table 3.

For the altered fiber tracts and point-wise location, we found no significant correlation between diffusion metrics and cognitive performance in aMCI or AD.

Table 2

Mean MD ( × 100) of 16 fiber tracts for HC, aMCI and AD. The left ATR, ILF, CST, CC, IFOF, SLF and forceps minor exhibited the significant difference between HC, aMCI and AD. Abbreviation: HC, health control; aMCI, amnestic mild cognitive impairment; AD, Alzheimer's Disease; MD, mean diffusivity; ATR, anterior thalamic radiation; CST, corticospinal tract; CC, cingulum cingulate; IFOF, inferior fronto-occipital fasciculus; ILF, inferior longitudinal fasciculus; SLF, superior longitudinal fasciculus; UF, uncinate fasciculus; R, right; L, left

Table 3

The location of tracts showing significant group differences in diffusion measures ( × 100) between HC, aMCI and AD. Abbreviation: HC, health control; aMCI, amnestic mild cognitive impairment; AD, Alzheimer's Disease; FA, fractional anisotropy; MD, mean diffusivity; DA, axial diffusivity; DR, radial diffusivity; ATR, left anterior thalamic radiation; CST, corticospinal tract; CC, cingulum cingulate; IFOF, inferior fronto-occipital fasciculus; UF, uncinate fasciculus; R, right; L, left.

Table 4

Discrimination results derived from the RF between HC, aMCI and AD. Abbreviation: HC, health control; aMCI, amnestic mild cognitive impairment; AD, Alzheimer's Disease; RF, random forest; FA, fractional anisotropy; MD, mean diffusivity; DA, axial diffusivity; DR, radial diffusivity.

Discrimination analysis

Table 4 showed the results of the RF for the disorder diagnosis based on diffusion metrics in the fiber tract level and point-wise level. Among these results, we only focused on the classification where accuracy was over 70%. The tract-level MD profile could be applied to distinguish aMCI from HC with the highest discrimination ability (accuracy = 75.51%; sensitivity = 80.00%; specificity = 80.83%). Furthermore, the analysis of the variable importance showed that the left IFOF was the most important tract contributing to HC VS aMCI classification (Figure 2A). With respect to differentiating AD from HC, the point-wise MD measurements presented the best classification performance (accuracy = 86.05%; sensitivity = 92.00%; specificity = 77.78%). The two most important variables were localized mainly in tracts along the left UF (nodes 75-100) and left ATR (nodes 1-13) (Figure 2B). In addition, the point-wise DA measurements had a significant role in the aMCI VS AD classification (accuracy = 77.78%; sensitivity = 66.67%; specificity = 61.11%), where the posterior component of the left CC (nodes 1-10) was the most important variable (Figure 2C). Other results about the variable importance differentiating AD from HC was presented in Supplementary Figure 3.

In this study, we applied a precise method of fiber-tract segmentation (AFQ) to identify the localized significance of aberrant white matter microstructure and further investigate their role in the diagnosis of AD. To be noted, we found the following points: (1) The left-sided microstructural vulnerability in the white matter fiber tract level in AD; (2) The frontal lobe portion of left UF and ATR playing the critical role in the diagnosis of AD; (3) The posterior component of the left CC as a neuroimaging marker of monitoring disease progression.

In our research, only DA, DR and MD values of white matter in the entire fiber tract or point-wise level exhibited the significant alterations. The DA indicates the diffusion coefficient parallel to the principal eigenvector and DR reflects the average diffusivity along the secondary axes, whereas MD is calculated as an average rate of all three diffusion axes. Higher MD values often imply impaired white matter integrity [26]. It has been proposed that DA is more sensitive to axonal damage while RD is more sensitive to myelin loss [26]. However, no significant alterations in FA (an index of the directionality of water diffusion) along fiber tracts were observed in our study. As reviewed by Amlien IK and Fjell AM, the increased DA could contribute to reduce between-group differences in FA, and MD and DR may thus be as more sensitive neuroimaging biomarkers of white matter damage in AD [27]. This similar pattern has also been demonstrated by a cross-sectional and longitudinal study, which revealed that increased MD and DA were the first abnormalities to occur in the early phase of AD [28].

The leftward white matter microstructural vulnerability in the fiber tract level

In the fiber tract level, these significantly altered fiber tracts (e.g. the left IFOF, ATR, CC, ILF, SLF, UF and CST) were mostly located in the left hemispheric. Previous studies have revealed that AD may appear to begin with or be characterized by the asymmetric left lateralized pattern of neurodegeneration. Earlier researches concerning brain metabolism in AD or individuals at risk for AD showed asymmetric cerebral glucose metabolic deficits detected with fludeoxyglucose F18, predominantly in parts with left hemispheric hypometabolism [29–30]. Recently, the longitudinal analysis using fludeoxyglucose positron emission tomography further demonstrated that Aβ positive patients with MCI indicated regional brain metabolic rate of glucose declines mainly located in the left temporal cortex, correlated with cognitive decline [31]. From the perspective of brain morphometry, asymmetric patterns of brain atrophy with a left lateralized pronunciation (particularly located in the left parietal and temporal lobe) have been reported in early stage of AD. As the disease progresses, gray matter loss becomes more symmetrical [32]. In addition, a meta-analyses focusing on hippocampal volume determined a left-less-than-right atrophy pattern in MCI and AD comparing to normal aging and MCI patients shown the strongest effect sizes [33]. However, previous DTI studies based on TBSS or VBM haven’t yielded the consistent result, possibly due to the difference of analytical approach. So far, no clear-cut mechanism has been proposed to explain why left hemispheric fiber tracts could be more susceptible in the progression of AD. Specific focus was given to the amyloid deposition showing a left laterality (mainly in dorsal frontal cortex and sensory-motor area) in MCI subjects [34]. Combining the white matter damage hypothesis in AD mentioned earlier, we infer that the left lateralized gray matter atrophy and amyloid deposition have a synergistic effect with the leftward white matter microstructural vulnerability in the fiber tract level.

It should be noted that the highest discrimination ability in identifying aMCI or AD from the normal elderly was obtained by the diffusion metrics of left IFOF among white matter tractography measures. The IFOF is a long cortico-cortical association tract that connects the orbitofrontal, posterior temporal, and the occipital areas. Remarkably, the left IFOF has been regarded as the ventral pathway involving semantic processing and executive function [35–36]. Analysis of the white matter microstructure in preclinical phases of AD has revealed that the cognitively normal elderly with positive Aβ-42 show increased DA in the left IFOF compared to the aged with negative Aβ-42 [37]. Moreover, the macroscopic research of white matter injury in AD also provided the evidence that the volume of white matter hyperintensity within IFOF was the highest among all fiber tracts and correlated with decreased functional connectivity in IFOF-connected areas of default mode network [38]. Therefore, the above findings indicated that left-sided white matter microstructural integrity in the fiber tract level may be more vulnerable and the left IFOF may be a potential biomarker for the early identification of AD.

The frontal lobe portion of left UF and ATR playing the important value in the diagnosis of AD

The AFQ technique can provide more information about white matter damage which is not obvious from the entire fiber bundles because the tissue properties of a fiber tract may change along the trajectory of the bundle. In point-wise comparison of MD profiles, twelve segmental components of eight fiber tracts displayed significant increased MD values in AD patients compared to HC. These altered metrics showed the best classification performance (accuracy = 86.05%) with respect to differentiating AD from HC. Moreover, the frontal lobe portion of left UF and ATR play the most critical role in the identification of AD.

The UF is a ventral long-range fiber tract that connects the lateral orbitofrontal cortex with the anterior temporal lobe, and is correlated with the formation and retrieval of episodic memory and other cognition [39]. A meta-analysis examining white matter microstructural disruption concluded that a large effect size was detected in the UF, while a small effect size was showed in occipital white matter in the comparison of AD with normal aged [40]. According to the retrogenesis model, the white matter deterioration in AD is the reverse of processing of myelogenesis [41]. Early-myelinated projection fibers such as the corticospinal tracts are affected last and least, whereas late-myelinated cortico-cortical association tracts are affected early in AD [41]. The UF is one of the latest myelinated fasciculus, and continues maturing until the third decade of life [39]. This might help explain why the UF is more susceptible to degeneration in AD. However, previous DTI studies have reported inconsistent findings in AD with some researches suggesting relatively lower FA and higher MD in the left UF [37] while others have revealed relatively lower FA and higher MD in the right UF [42] or in the bilateral UF [43–44]. Our results further demonstrated that AD patients exhibited the increased MD in the frontal lobe portion of bilateral UF rather than in the entire fiber tract of UF and the frontal lobe portion of left UF in diagnosis of AD was relatively more important. The potential pathophysiological mechanism of the vulnerability in the frontal lobe portion of the left UF still needs to be investigated by further studies.

Another specific anatomical localization of the fiber tract contributing to determining AD patients from the elderly is the frontal lobe portion of left ATR. The ATR consists of nerve fibers connecting anterior and mediodorsal thalamic nuclei to the anterior cingulate cortex and prefrontal cortex, and has been regarded as the important structural pathway of cognition and behavior [45]. Our result is partially consistent with a previous study in which the individuals with subjective cognitive impairment have presented disrupted white matter integrity in the left ATR, indicating that the left ATR may serve as early marker of AD spectrum [46]. Additionally, the macroscopic white matter research found a strict relationship between the presence of white matter lesions in the ATR and the severity of apathy (a risk factor of conversion to dementia) in aMCI [47]. The imaging genetics studies suggested that the genetic variant (e.g., superoxide dismutase 2 and catalase genes and the human neuregulin-1 gene) may mediate cognitive and behavioral abnormality through their effects on brain structure in the ATR [48–49]. The evidence that Aβ and NFT deposition preferentially occurred in the prefrontal may provide the potential mechanism of the ATR’s prefrontal portion as a diagnostic biomarker [50–51].

The posterior component of the left CC as a neuroimaging marker of monitoring disease progression

Sexton et al reviewed AD-related DTI studies and proposed that integrity difference varied along the CC and the largest effect size was in the posterior portion [40]. This pattern was similar to our result that the point-wise DA measurements had a significant role in differentiating the AD from aMCI, where the posterior component of the left CC was the most important variable. Although the left IFOF, UF and ATR played the critical role in identifying aMCI or AD from normal controls as mentioned above, the posterior component of left CC was relatively more important in the aspect of monitoring disease progression. The neuronal cell bodies of the CC are located mainly in the posterior cingulate cortex (PCC) and the posterior component of the CC is adjacent to the PCC. Despite structural neuroimaging researches have consistently suggested the earliest gray matter atrophy in the medial temporal lobe (e.g., entorhinal cortex and hippocampus) in AD spectrum [52], functional imaging studies have shown that hypoperfusion or hypometabolism first occur in the PCC [53]. The PCC functional deficit has been hypothetically explained by direct effect of AD-related pathological deposition and PCC atrophy and the indirect effect of medial temporal lobe atrophy [54]. Thus, according to the Wallerian-like degeneration, the posterior CC dysfunction may be secondary to PCC functional deficit in AD [54]. It still needs additional confirmation by longitudinal follow-up studies.

There were several potential limitations to this research. First, these observations in our cross-sectional study were made in a relatively small sample and still require further investigation by prospective studies on large populations. Second, the AD and aMCI diagnosis was not based on AD-related biomarkers but only the neuropsychological assessments. This might cause imprecise diagnosis. Third, due to the strict criterion in the fiber tracking, the fiber tracts like bilateral arcuate fasciculus and bilateral cingulum hippocampus tracts were failed to track in some subjects. Finally, association analyses showed that cognitive performance in aMCI or AD was not correlated with any of the significantly changed DTI metrics. This might result from our small sample size and the loss of multiple neuropsychological scores in AD patients.

Combining a tractography approach with RF analyses, our study indicated abnormal tissue diffusion measures of global and local fiber tracts and their powerful diagnostic ability in aMCI and AD patients. We found that the left-sided microstructural integrity was vulnerable in the white matter fiber tract level in AD. Furthermore, the frontal lobe portion of left UF and ATR and the posterior component of the left CC played the critical role in the diagnosis and surveillance of AD. Our findings lent support to the viewpoint of white matter abnormalities as a diagnostic biomarker and provided deeper understanding of white matter changes in AD.

Alzheimer’s disease; Aβ:amyloid plaques; NFT:neurofibrillary tangles; CSF:cerebrospinal fluid; DTI:diffusion tensor imaging; FA:fractional anisotropy;MD:mean diffusivity; ROI:regions of interest; VBM:voxel-based morphometry; TBSS:tract-based spatial statistics; MCI:mild cognitive impairment; AFQ:automated fiber quantification; DR:radial diffusivity; ATR:anterior thalamic radiation; CST:corticospinal tract; CC:cingulum cingulate; CH:cingulum hippocampus; IFOF:inferior fronto-occipital fasciculus; ILF:inferior longitudinal fasciculus; SLF:superior longitudinal fasciculus; UF:uncinate fasciculus; AF:arcuate fasciculus; DA:axial diffusivity; HC:healthy controls; aMCI:amnestic mild cognitive impairment; RF:random forest; NINCDS-ADRDA:National Institute of Neurological and Communicative Disorders and Stroke and the AD and Related Disorders Association; DSM-IV:Diagnostic and Statistical Manual of Mental Disorders IV criteria; MMSE:mini mental state examination; AVLT-DR:Auditory Verbal Learning Test-delayed recall; VR-DR:visual reproduction-delay recall; WMS:Wechsler Memory Scale; CVF:category verbal fluency; BNT:Boston Naming Test; CDT:Clock Drawing Test; VR-C:visual reproduction-copy; TMT:Trail Making Test; DWI:diffusion-weighted imaging; TE:echo time; TR:repetition time; TI:time interval; ANOVA:analysis of variance; GLM:general linear model; FDR:false discovery rate; OOB:out-of-bag; PCC:posterior cingulate cortex.

Ethics approval and consent to participate

This research was approved by the Ethics Committee of Nanjing Drum Tower Hospital. Informed consents were obtained from all participants.

Consent for publication

Not applicable.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Competing Interests

The authors have declared that no competing interest exists.

Funding

This research was partly supported by the National Natural Science Foundation of China (No. 81822013; 81671665), the National Key Research and Development Program of China (2016YFC1300500-504), Jiangsu Provincial Key Medical Talents (No. ZDRCA2016085), Jiangsu Province Key Medical Discipline (ZDXKA2016020) and the Key Research and Development Program of Jiangsu Province of China (BE2016610).

Authors’ contributions

FB and HZ designed this study. HFC wrote the manuscript. HFC, RMQ, CML, MCL and RYL analyzed the data. BZ, YX, FB and HZ revised the manuscript. All authors read and approved the final manuscript.

Author details

Department of Neurology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China
The State Key Laboratory of Pharmaceutical Biotechnology, Institute of Brain Science, Nanjing University, Nanjing, China
Jiangsu Province Stroke Center for Diagnosis and Therapy, Nanjing, China
Nanjing Neuropsychiatry Clinic Medical Center, Nanjing, China
Department of Radiology, Drum Tower Hospital, Medical School of Nanjing University, Nanjing, China

GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18(1): 88–106.
Pini L, Pievani M, Bocchetta M, Altomare D, Bosco P, Cavedo E, Galluzzi S, Marizzoni M, Frisoni GB. Brain atrophy in Alzheimer’s Disease and aging. Ageing Res Rev. 2016; 30: 25–48.
Nasrabady SE, Rizvi B, Goldman JE, Brickman AM. White matter changes in Alzheimer’s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol Commun. 2018; 6(1): 22.
Leys D, Pruvo JP, Parent M, Vermersch P, Soetaert G, Steinling M, Delacourte A, Défossez A, Rapoport A, Clarisse J. Could Wallerian degeneration contribute to "leuko-araiosis" in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry. 1991; 54(1): 46–50.
McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M, Martin-Ruiz C, Taylor JP, Thomas AJ, McKeith IG, De Carli C, Attems J. Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease. Acta Neuropathol. 2017; 134(3): 459–473.
Dean DC 3rd, Hurley SA, Kecskemeti SR, O'Grady JP, Canda C, Davenport-Sis NJ, Carlsson CM, Zetterberg H, Blennow K, Asthana S, Sager MA, Johnson SC, Alexander AL, Bendlin BB. Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease. JAMA Neurol. 2017; 74(1): 41–49.
Nowrangi MA, Lyketsos CG, Leoutsakos JM, Oishi K, Albert M, Mori S, Mielke MM. Longitudinal, region-specific course of diffusion tensor imaging measures in mild cognitive impairment and Alzheimer’s disease. Alzheimers Dement. 2013; 9(5): 519 – 28.
Kantarci K, Murray ME, Schwarz CG, Reid RI, Przybelski SA, Lesnick T, Zuk SM, Raman MR, Senjem ML, Gunter JL, Boeve BF, Knopman DS, Parisi JE, Petersen RC, Jack CR Jr, Dickson DW. White-matter integrity on DTI and the pathologic staging of Alzheimer’s disease. Neurobiol Aging. 2017; 56: 172–179.
Yeatman JD, Dougherty RF, Rykhlevskaia E, Sherbondy AJ, Deutsch GK, Wandell BA, Ben-Shachar M. Anatomical properties of the arcuate fasciculus predict phonological and reading skills in children. J Cogn Neurosci. 2011; 23(11): 3304-17.
Weiler M, Agosta F, Canu E, Copetti M, Magnani G, Marcone A, Pagani E, Balthazar ML, Comi G, Falini A, Filippi M. Following the Spreading of Brain Structural Changes in Alzheimer’s Disease: A Longitudinal, Multimodal MRI Study. J Alzheimers Dis. 2015; 47(4): 995–1007.
Goodrich-Hunsaker NJ, Abildskov TJ, Black G, Bigler ED, Cohen DM, Mihalov LK, Bangert BA, Taylor HG, Yeates KO. Age- and sex-related effects in children with mild traumatic brain injury on diffusion magnetic resonance imaging properties: A comparison of voxelwise and tractography methods. J Neurosci Res. 2018; 96(4): 626–641.
Yeatman JD, Dougherty RF, Myall NJ, Wandell BA, Feldman HM. Tract profiles of white matter properties: automating fiber-tract quantification. PLoS One. 2012; 7(11): e49790.
Deng F, Wang Y, Huang H, Niu M, Zhong S, Zhao L, Qi Z, Wu X, Sun Y, Niu C, He Y, Huang L, Huang R. Abnormal segments of right uncinate fasciculus and left anterior thalamic radiation in major and bipolar depression. Prog Neuropsychopharmacol Biol Psychiatry. 2018; 81: 340–349.
Sun H, Lui S, Yao L, Deng W, Xiao Y, Zhang W, Huang X, Hu J, Bi F, Li T, Sweeney JA, Gong Q. Two Patterns of White Matter Abnormalities in Medication-Naive Patients With First-Episode Schizophrenia Revealed by Diffusion Tensor Imaging and Cluster Analysis. JAMA Psychiatry. 2015; 72(7): 678 – 86.
Huber E, Donnelly PM, Rokem A, Yeatman JD. Rapid and widespread white matter plasticity during an intensive reading intervention. Nat Commun. 2018; 9(1): 2260.
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology. 1984;34(7):939–44.
American Psychiatric Association. DSM-IV: Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Am. Psychiatric Assoc. Press; 1994.
Petersen RC. Mild cognitive impairment as a diagnostic entity. J Intern Med. 2004;256(3):183–94.
Chen H, Su F, Ye Q, Wang Z, Shu H, Bai F. The Dose-Dependent Effects of Vascular Risk Factors on Dynamic Compensatory Neural Processes in Mild Cognitive Impairment. Front Aging Neurosci. 2018;10:131.
Liu R, Chen H, Qin R, Gu Y, Chen X, Zou J, Jiang Y, Li W, Bai F, Zhang B, Wang X, Xu Y. The Altered Reconfiguration Pattern of Brain Modular Architecture Regulates Cognitive Function in Cerebral Small Vessel Disease. Front Neurol. 2019;10:324.
Wakana S, Caprihan A, Panzenboeck MM, Fallon JH, Perry M, Gollub RL, Hua K, Zhang J, Jiang H, Dubey P, Blitz A, van Zijl P, Mori S. Reproducibility of quantitative tractography methods applied to cerebral white matter. Neuroimage. 2007;36(3):630–44.
Hua K, Zhang J, Wakana S, Jiang H, Li X, Reich DS, Calabresi PA, Pekar JJ, van Zijl PC, Mori S. Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage. 2008; 39(1): 336 – 47.
Johnson RT, Yeatman JD, Wandell BA, Buonocore MH, Amaral DG, Nordahl CW. Diffusion properties of major white matter tracts in young, typically developing children. Neuroimage. 2014;88:143–54.
Banfi C, Koschutnig K, Moll K, Schulte-Körne G, Fink A, Landerl K. White matter alterations and tract lateralization in children with dyslexia and isolated spelling deficits. Hum Brain Mapp. 2019;40(3):765–76.
Numan T, Slooter AJC, van der Kooi AW, Hoekman AML, Suyker WJL, Stam CJ, van Dellen E. Functional connectivity and network analysis during hypoactive delirium and recovery from anesthesia. Clin Neurophysiol. 2017;128(6):914–24.
Bennett IJ, Madden DJ. Disconnected aging: cerebral white matter integrity and age-related differences in cognition. Neuroscience. 2014; 276: 187–205.
Amlien IK, Fjell AM. Diffusion tensor imaging of white matter degeneration in Alzheimer’s disease and mild cognitive impairment. Neuroscience. 2014; 276: 206 – 15.
Acosta-Cabronero J, Alley S, Williams GB, Pengas G, Nestor PJ. Diffusion tensor metrics as biomarkers in Alzheimer’s disease. PLoS One. 2012; 7(11): e49072.
Small GW, Mazziotta JC, Collins MT, Baxter LR, Phelps ME, Mandelkern MA, Kaplan A, La Rue A, Adamson CF, Chang L. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA. 1995; 273(12): 942-7.
Loewenstein DA, Barker WW, Chang JY, Apicella A, Yoshii F, Kothari P, Levin B, Duara R. Predominant left hemisphere metabolic dysfunction in dementia. Arch Neurol. 1989; 46(2): 146 – 52.
Weise CM, Chen K, Chen Y, Kuang X, Savage CR, Reiman EM; Alzheimer’s Disease Neuroimaging Initiative. Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment. Neuroimage Clin. 2018; 20: 286–296.
Janke AL, de Zubicaray G, Rose SE, Griffin M, Chalk JB, Galloway GJ. 4D deformation modeling of cortical disease progression in Alzheimer’s dementia. Magn Reson Med. 2001; 46(4): 661-6.
Shi F, Liu B, Zhou Y, Yu C, Jiang T. Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer’s disease: Meta-analyses of MRI studies. Hippocampus. 2009; 19(11): 1055-64.
Raji CA, Becker JT, Tsopelas ND, Price JC, Mathis CA, Saxton JA, Lopresti BJ, Hoge JA, Ziolko SK, DeKosky ST, Klunk WE. Characterizing regional correlation, laterality and symmetry of amyloid deposition in mild cognitive impairment and Alzheimer’s disease with Pittsburgh Compound B. J Neurosci Methods. 2008; 172(2): 277 – 82.
Epstein KA, Cullen KR, Mueller BA, Robinson P, Lee S, Kumra S. White matter abnormalities and cognitive impairment in early-onset schizophrenia-spectrum disorders. J Am Acad Child Adolesc Psychiatry. 2014; 53(3): 362 – 72.e1-2.
Sierpowska J, Gabarrós A, Fernández-Coello A, Camins À, Castañer S, Juncadella M, François C, Rodríguez-Fornells A. White-matter pathways and semantic processing: intrasurgical and lesion-symptom mapping evidence. Neuroimage Clin. 2019; 22: 101704.
Molinuevo JL, Ripolles 2, Simó M, Lladó A, Olives J, Balasa M, Antonell A, Rodriguez-Fornells A, Rami L. White matter changes in preclinical Alzheimer’s disease: a magnetic resonance imaging-diffusion tensor imaging study on cognitively normal older people with positive amyloid β protein 42 levels. Neurobiol Aging. 2014; 35(12): 2671–2680.
Taylor ANW, Kambeitz-Ilankovic L, Gesierich B, Simon-Vermot L, Franzmeier N, Araque Caballero MÁ, Müller S, Hesheng L, Ertl-Wagner B, Bürger K, Weiner MW, Dichgans M, Duering M, Ewers M; Alzheimer’s Disease Neuroimaging Initiative (ADNI). Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer’s disease. Alzheimers Dement. 2017; 13(3): 225–235.
Olson IR, Von Der Heide RJ, Alm KH, Vyas G. Development of the uncinate fasciculus: Implications for theory and developmental disorders. Dev Cogn Neurosci. 2015; 14: 50–61.
Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP. A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging. 2011; 32(12): 2322.e5-18.
Rubial-Álvarez S, de Sola S, Machado MC, Sintas E, Böhm P, Sánchez-Benavides G, Langohr K, Muñiz R, Peña-Casanova J. The comparison of cognitive and functional performance in children and Alzheimer’s disease supports the retrogenesis model. J Alzheimers Dis. 2013; 33(1): 191–203.
Vipin A, Ng KK, Ji F, Shim HY1, Lim JKW, Pasternak O, Zhou JH; Alzheimer’s Disease Neuroimaging Initiative. Amyloid burden accelerates white matter degradation in cognitively normal elderly individuals. Hum Brain Mapp. 2019; 40(7): 2065–2075.
Mayo CD, Mazerolle EL, Ritchie L, Fisk JD, Gawryluk JR; Alzheimer’s Disease Neuroimaging Initiative. Longitudinal changes in microstructural white matter metrics in Alzheimer’s disease. Neuroimage Clin. 2016; 13: 330–338.
Rémy F, Vayssière N, Saint-Aubert L, Barbeau E, Pariente J. White matter disruption at the prodromal stage of Alzheimer’s disease: relationships with hippocampal atrophy and episodic memory performance. Neuroimage Clin. 2015; 7: 482 – 92.
Mamah D, Conturo TE, Harms MP, Akbudak E, Wang L, McMichael AR, Gado MH, Barch DM, Csernansky JG. Anterior thalamic radiation integrity in schizophrenia: a diffusion-tensor imaging study. Psychiatry Res. 2010; 183(2): 144 – 50.
Shao W, Li X, Zhang J, Yang C, Tao W, Zhang S, Zhang Z, Peng D. White matter integrity disruption in the pre-dementia stages of Alzheimer’s disease: from subjective memory impairment to amnestic mild cognitive impairment. Eur J Neurol. 2019; 26(5): 800–807.
Torso M, Serra L, Giulietti G, Spanò B, Tuzzi E, Koch G, Caltagirone C, Cercignani M, Bozzali M. Strategic lesions in the anterior thalamic radiation and apathy in early Alzheimer’s disease. PLoS One. 2015; 10(5): e0124998.
Salminen LE, Schofield PR, Pierce KD, Bruce SE, Griffin MG, Tate DF, Cabeen RP, Laidlaw DH, Conturo TE, Bolzenius JD, Paul RH. Vulnerability of white matter tracts and cognition to the SOD2 polymorphism: A preliminary study of antioxidant defense genes in brain aging. Behav Brain Res. 2017; 329: 111–119.
Barnes A, Isohanni M, Barnett JH, Pietiläinen O, Veijola J, Miettunen J, Paunio T, Tanskanen P, Ridler K, Suckling J, Bullmore ET, Jones PB, Murray GK. Neuregulin-1 genotype is associated with structural differences in the normal human brain. Neuroimage. 2012; 59(3): 2057-61.
Lo AC, Iscru E, Blum D, Tesseur I, Callaerts-Vegh Z, Buée L, De Strooper B, Balschun D, D'Hooge R. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer’s disease. J Alzheimers Dis. 2013; 37(1): 109 – 25.
Tsartsalis S, Xekardaki A, Hof PR, Kövari E, Bouras C. Early Alzheimer-type lesions in cognitively normal subjects. Neurobiol Aging. 2018; 62: 34–44.
Moscoso A, Silva-Rodríguez J, Aldrey JM, Cortés J, Fernández-Ferreiro A, Gómez-Lado N, Ruibal Á, Aguiar P; Alzheimer’s Disease Neuroimaging Initiative. Prediction of Alzheimer’s disease dementia with MRI beyond the short-term: Implications for the design of predictive models. Neuroimage Clin. 2019; 23: 101837.
Teipel S, Grothe MJ; Alzheimer’s Disease Neuroimaging Initiative. Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer’s disease? Eur J Nucl Med Mol Imaging. 2016; 43(3): 526 – 36.
Choo IH, Lee DY, Oh JS, Lee JS, Lee DS, Song IC, Youn JC, Kim SG, Kim KW, Jhoo JH, Woo JI. Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer’s disease. Neurobiol Aging. 2010; 31(5): 772-9.

Download PDF

Version 1

posted

You are reading this latest preprint version

Aberrant White Matter Microstructure as a Potential Diagnostic Marker in Alzheimer’s Disease by Automated Fiber Quantification

Status:

Version 1

Abstract

Figures

Background

Methods

Participants

MRI scanning

Neuropsychological mesurement

Magnetic resonance image pre-processing

Automated fiber quantification procedure

Statistical and machine learning analyses

Results

Demographic and clinical characteristics

Between-group difference in diffusion metrics and its relationship with cognition

Discrimination analysis

Discussion

The leftward white matter microstructural vulnerability in the fiber tract level

The posterior component of the left CC as a neuroimaging marker of monitoring disease progression

Conclusion

Abbreviations

Declarations

References

Supplementary Files

Status:

Version 1